AIM

XASE

AIM ImmunoTech Inc.

Mkt Cap $5MBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FUNDAMENTALS

P/S

48.15

EV/EBITDA

-0.50

P/B

-0.43

EPS (TTM)

$-1.71

ROE

142.7%

ROA

-241.4%

MKT CAP

$4.2M

TECHNICAL ANALYSIS

Mixed

RSI-14

40.4

Neutral

MACD

-0.060

Bullish

SMA-50

$0.72

SMA-200

$1.98

BOLL %B

0.39

Within bands

ATR-14

$0.07

RVOL

0.01x

Low activity

MOMENTUM

-0.3%

10d -3.9% / 30d -26.2%

Analysis History

AI PREDICTION

No prediction yet

Tap Analyze to generate

REVENUE & GROWTH

$21,000

Revenue

-19.2%

QoQ

-53.3%

YoY

Gross Margin

-90.5%Expanding

ANALYST CONSENSUS

80% Buy

4 Buy1 Hold0 Sell

Low

$10

Mean

$10

High

$11

SHORT & FLOAT

Free Float

96.1%

Latest Headlines

AIM ImmunoTech Provides Routine Update on Annual Filings

GlobeNewswire Inc.4/13/2026